Breaking the Biofilm Barrier: How NATROX® O₂ Helps Restore Healing in Chronic Wounds

Biofilm — the Hidden Barrier to Healing

Biofilms are one of the most persistent challenges in chronic wound care. Evidence suggests that up to 100% of non-healing wounds contain biofilm, which can delay or prevent healing altogether (WUWHS, 2016).

These structured bacterial communities form within hours and mature within just 2–4 days. Protected by a self-produced matrix of sugars and proteins, biofilms are highly resistant to antibiotics, antiseptics, and host immunity (IWII, 2016). Even silver-based dressings have been shown to have limited effect against mature biofilms (Jamal et al., 2015).

As a result, clinicians are turning to novel adjunctive therapies—including topical oxygen therapy (TOT)—to help overcome biofilm-related wound chronicity.

The Link Between Oxygen and Wound Chronicity

Oxygen plays a vital role in every phase of wound healing—from cellular metabolism and ATP production to collagen synthesis and cell proliferation.

When oxygen levels are low (hypoxia), several problems occur:

  • Immune cells like neutrophils and macrophages can’t generate enough reactive oxygen species (ROS) to destroy bacteria (Allen et al., 1997).
  • Reduced ROS production allows biofilms to establish and persist.
  • Bacteria consume oxygen, further worsening hypoxia and perpetuating the “non-healing cycle.”

This means restoring oxygen at the wound site can directly influence biofilm disruption and tissue regeneration.

How Topical Oxygen Therapy (TOT) Disrupts Biofilm

Research published by Wounds International (2018) demonstrates that topical oxygen therapy can help reverse biofilm-induced stagnation in chronic wounds.

By supplying oxygen directly to the wound bed, topical oxygen therapy helps:

  • Increase bacterial metabolism within biofilms, making them more susceptible to antimicrobials.
  • Support the host immune response by improving oxidative killing mechanisms.
  • Prevent recolonization and recurrence of biofilm formation.

In short, oxygen helps break the biofilm cycle and creates an environment conducive to healing.

NATROX® O₂: Proven Continuous Topical Oxygen Therapy for Biofilm Management

NATROX® O₂ Continuous Topical Oxygen Therapy (Inotec AMD Ltd) delivers highly concentrated oxygen continuously to the wound site via a small, wearable device. It is clinically proven to improve healing outcomes in hard-to-heal and chronic wounds (Yu et al., 2016; Harding, 2016).

Key benefits include:

  • Continuous oxygen delivery (24/7): Maintains optimal oxygenation during all healing stages.
  • Biofilm management: Alters the wound’s microbiome, shifting it from anaerobic to aerobic dominance.
  • Enhanced healing rates: In clinical trials, NATROX® O₂ therapy accelerated closure of Grade II and III diabetic foot ulcers compared to standard of care.
  • Patient-friendly design: Wearable, silent, and battery-operated for minimal disruption to daily life.

A follow-up biofilm study showed that wounds treated with NATROX® O₂ transitioned from anaerobic to aerobic bacterial flora within two weeks, correlating with improved healing outcomes. This suggests that topical oxygen not only promotes closure but also reshapes the wound microbiome for lasting recovery.

Integrating NATROX® O₂ into a Biofilm-Based Wound Care Pathway

If biofilm is suspected and the wound is not progressing (e.g., <40–50% reduction after 4 weeks of best practice), consider treatment with NATROX® O₂. The following steps may support improved outcomes:

  1. Debride the wound to remove necrotic tissue and surface biofilm.
  2. Prepare the wound bed (e.g., TIME framework).
  3. Initiate Continuous Topical Oxygen Therapy with NATROX® O₂ to restore oxygen balance and suppress biofilm reformation.
  4. Adjust dressings for exudate changes during the first two weeks of therapy.
  5. Continue NATROX® O₂ therapy until wound closure and consider short-term continuation post-healing to prevent recurrence.

Summary: Overcoming Biofilm with Oxygen

Biofilm is a major cause of wound chronicity and treatment failure. Its resistance to conventional antimicrobials highlights the urgent need for innovative, non-pharmacologic strategies.

Continuous Topical Oxygen Therapy, as delivered by NATROX® O₂, offers a clinically supported solution to help disrupt biofilms, enhance immune function, and restore stalled healing.

“Topical oxygen therapy can be a valuable adjunct in the management of biofilm-related chronic wounds, helping to transform non-healing wounds into healing ones.” – Wounds International, 2018

References

  • Allen DB et al. (1997). Arch Surg 132: 991–6.
  • Harding K (2016). The essential role of oxygen in wound healing. Wounds UK.
  • Jamal M et al. (2015). Res Rev J Microbiol Biotechnol 4(3): 1–14.
  • World Union of Wound Healing Societies (2016). Management of Biofilm.
  • Wounds International (2018). Challenging wounds, improving outcomes: Biofilm management with topical oxygen therapy.
  • Yu J et al. (2016). Wound Repair Regen 24(6): 1066–72.
DOWNLOAD RESOURCE